Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR assays in lung cancer.

Advances in anatomic pathology - 1 Jul 2008

Dacic Sanja

Abstract excerpt

The development of small-molecule inhibitors of the epidermal growth factor receptor (EGFR) resulted in new therapeutic options for patients with advanced lung cancer. It was clear from the experience with targeted therapy for breast cancer that a new standardized assay procedure for assessing an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization, Fluorescence

Share to Lung Neoplasms

Share to Mutation

Share to Polymerase Chain Reaction

Share to Prognosis

Source

Identifiers

PMID: 18580100
DOI: 10.1097/PAP.0b013e31817bf5a9

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18580100-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR assays in lung cancer.PMID 18580100Read ↗

Biological and clinical implications of EGFR mutations in lung cancer.Semantic proximity Read ↗

Pharmacogenetics of EGFR in Lung Cancer: Perspectives and Clinical ApplicationsSemantic proximity Read ↗

A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung CancerSemantic proximity Read ↗

Mapping EGFR1 mutations in patients with lung adenocarcinoma.Semantic proximity Read ↗

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.Semantic proximity Read ↗

Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay.Semantic proximity Read ↗

The Biology of Epidermal Growth Factor Receptor in Lung CancerSemantic proximity Read ↗

A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and ImmunohistochemistrySemantic proximity Read ↗

Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma.Semantic proximity Read ↗

First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.Semantic proximity Read ↗

EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.